D.E. Shaw & Co’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-137
| Closed | -$12K | – | 2862 |
|
2020
Q2 | $12K | Hold |
137
| – | – | ﹤0.01% | 2592 |
|
2020
Q1 | $15K | Sell |
137
-998
| -88% | -$109K | ﹤0.01% | 2620 |
|
2019
Q4 | $278K | Sell |
1,135
-149
| -12% | -$36.5K | ﹤0.01% | 2392 |
|
2019
Q3 | $442K | Sell |
1,284
-1,638
| -56% | -$564K | ﹤0.01% | 2128 |
|
2019
Q2 | $2.69M | Buy |
2,922
+1,406
| +93% | +$1.29M | ﹤0.01% | 1480 |
|
2019
Q1 | $2.42M | Sell |
1,516
-565
| -27% | -$901K | ﹤0.01% | 1482 |
|
2018
Q4 | $3.89M | Sell |
2,081
-1,203
| -37% | -$2.25M | 0.01% | 1221 |
|
2018
Q3 | $7.75M | Sell |
3,284
-1,432
| -30% | -$3.38M | 0.01% | 924 |
|
2018
Q2 | $16.2M | Buy |
4,716
+1,631
| +53% | +$5.62M | 0.02% | 643 |
|
2018
Q1 | $8.75M | Sell |
3,085
-1,680
| -35% | -$4.77M | 0.01% | 822 |
|
2017
Q4 | $12.3M | Buy |
4,765
+66
| +1% | +$170K | 0.02% | 679 |
|
2017
Q3 | $13.3M | Sell |
4,699
-457
| -9% | -$1.3M | 0.02% | 593 |
|
2017
Q2 | $12.2M | Buy |
5,156
+1,476
| +40% | +$3.49M | 0.02% | 625 |
|
2017
Q1 | $9.27M | Sell |
3,680
-2,099
| -36% | -$5.29M | 0.02% | 723 |
|
2016
Q4 | $13M | Buy |
5,779
+198
| +4% | +$447K | 0.02% | 602 |
|
2016
Q3 | $14M | Buy |
5,581
+1,016
| +22% | +$2.55M | 0.02% | 533 |
|
2016
Q2 | $14M | Buy |
4,565
+19
| +0.4% | +$58.2K | 0.03% | 543 |
|
2016
Q1 | $14.4M | Buy |
4,546
+3,113
| +217% | +$9.88M | 0.03% | 519 |
|
2015
Q4 | $7.36M | Buy |
1,433
+1,184
| +476% | +$6.08M | 0.01% | 781 |
|
2015
Q3 | $794K | Buy |
249
+167
| +204% | +$533K | ﹤0.01% | 1833 |
|
2015
Q2 | $326K | Sell |
82
-122
| -60% | -$485K | ﹤0.01% | 2309 |
|
2015
Q1 | $813K | Buy |
204
+8
| +4% | +$31.9K | ﹤0.01% | 1859 |
|
2014
Q4 | $959K | Sell |
196
-357
| -65% | -$1.75M | ﹤0.01% | 1722 |
|
2014
Q3 | $2.25M | Buy |
+553
| New | +$2.25M | ﹤0.01% | 1184 |
|
2014
Q1 | – | Sell |
-105
| Closed | -$368K | – | 2622 |
|
2013
Q4 | $368K | Buy |
+105
| New | +$368K | ﹤0.01% | 2075 |
|